Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
andC, andK, Avtotehna, baumanii, bifurcation, biotech, Canada, Carlo, categorized, category, choice, comparison, departure, difficle, disclaimer, dismissal, dismissed, DoH, Ebola, Ernst, father, footnote, greatest, JAZMP, job, Julian, Kirk, Ljubljana, lowest, Monte, newer, NOL, noncancelable, OTCQB, perspective, pilot, pronouncement, PTA, Randal, redeem, redeemable, redeemed, redemption, riskier, Secretary, Slovenian, software, Subtopic, targetingC, thereon, translation, undiscounted, Wendy
Removed:
allocable, allocation, amend, Amsterdam, AMT, assumed, awarded, calculation, Children, computing, construction, contracted, correction, COSO, creation, discontinued, feasibility, implement, indemnify, Initiative, International, interpretation, jurisdiction, leasing, likelihood, objective, offered, Philadelphia, pink, prepare, pursuit, raw, remained, reserve, retroactive, slightly, spent, Sponsoring, sublicensing, temporary, tolerability, Treadway, undelivered, workforce, worth
Filing tables
Filing exhibits
ARMP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-1 No. 333-193458) of AmpliPhi Biosciences Corporation and in the related Prospectus of our report dated April 15, 2015, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Richmond, Virginia
April 15, 2015